Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind Placebo-controlled Phase III Trial of Coenzyme Q10 in Gulf War Illness

NCT02865460 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02865460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02865460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind Placebo-controlled Phase III Trial of Coenzyme Q10 in Gulf War Illness
Lead sponsor
VA Office of Research and Development
Phase
Phase 3
Overall status
Completed
Start date
July 24, 2017
Completion date
December 31, 2020
Enrollment
100 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue, coenzyme q10, gulf war illness, ubiquinol